The activation of β2-ARs promotes tumor growth through vascular endothelial growth factor (VEGF) and metalloproteases, thus potentiating angiogenesis and metastasization in ovarian, lung, and breast cancer [50]. The gene discussed is VEGFA; the disease is breast carcinoma.